XSHE002391
Market cap435mUSD
Jan 09, Last price
5.02CNY
1D
0.60%
1Q
3.93%
Jan 2017
-56.92%
IPO
-65.44%
Name
Jiangsu Changqing Agrochemical Co Ltd
Chart & Performance
Profile
Jiangsu Changqing Agrochemical Co., Ltd. manufactures and sells pesticides in China, Europe, the United States, and Southeast Asia. Its technical materials comprise fomesafen, acifluorfen, fluoroglycofen-ethyl, lactofen, clomazone, imazethapyr, bromoxynil octanoate, nicosulfuron, benazolin-ethyl, clethodim, tricyclazole, fenoxanil, imidacloprid, acetamiprid, diafenthiuron, mesotrione, s-metolachlor, clodinafop-propargyl, dicamba, indoxacarb, fipronil, thiamethoxam, indoxacarb technical concentrate, clethodim mother liquor, cyhalofop-butyl active compound, prosulfuron active compound, pretilachlor active compound, azoxystrobin active compound, glyphosate active compound, chlorpyrifos active compound, triazophos, dimethazone, and triasulfuron active compound materials; and formulations include insecticides, bactericides, and herbicides. The company is based in Yangzhou, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 3,614,478 -14.83% | 4,243,593 12.72% | |||||||
Cost of revenue | 3,318,524 | 3,803,315 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 295,954 | 440,277 | |||||||
NOPBT Margin | 8.19% | 10.38% | |||||||
Operating Taxes | (16,279) | 9,558 | |||||||
Tax Rate | 2.17% | ||||||||
NOPAT | 312,233 | 430,719 | |||||||
Net income | 73,114 -72.13% | 262,351 5.56% | |||||||
Dividends | (207,273) | (129,921) | |||||||
Dividend yield | 5.06% | 2.85% | |||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 1,337,751 | 867,485 | |||||||
Long-term debt | 678,560 | 822,672 | |||||||
Deferred revenue | 7,119 | 8,230 | |||||||
Other long-term liabilities | 158,737 | ||||||||
Net debt | 1,261,821 | 639,869 | |||||||
Cash flow | |||||||||
Cash from operating activities | (77,892) | 845,087 | |||||||
CAPEX | (1,036,205) | ||||||||
Cash from investing activities | (535,995) | ||||||||
Cash from financing activities | 589,856 | ||||||||
FCF | (467,879) | 105,441 | |||||||
Balance | |||||||||
Cash | 675,732 | 1,050,288 | |||||||
Long term investments | 78,758 | ||||||||
Excess cash | 573,765 | 838,109 | |||||||
Stockholders' equity | 2,189,520 | 2,507,553 | |||||||
Invested Capital | 6,189,329 | 5,491,278 | |||||||
ROIC | 5.35% | 8.09% | |||||||
ROCE | 4.38% | 6.95% | |||||||
EV | |||||||||
Common stock shares outstanding | 649,593 | 649,593 | |||||||
Price | 6.30 -10.38% | 7.03 -13.00% | |||||||
Market cap | 4,092,433 -10.38% | 4,566,636 -11.25% | |||||||
EV | 5,356,613 | 5,219,138 | |||||||
EBITDA | 651,773 | 749,269 | |||||||
EV/EBITDA | 8.22 | 6.97 | |||||||
Interest | 68,848 | 59,053 | |||||||
Interest/NOPBT | 23.26% | 13.41% |